Bicara Therapeutics, Inc. (BCAX)
20.03
+0.74
(+3.84%)
USD |
NASDAQ |
May 19, 16:00
20.06
+0.03
(+0.15%)
After-Hours: 20:00
Bicara Therapeutics Total Assets (Quarterly) : 553.60M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Bridgebio Oncology Therapeutics, Inc. | 417.65M |
| Viridian Therapeutics, Inc. | 789.02M |
| ACADIA Pharmaceuticals, Inc. | 1.605B |
| Agenus, Inc. | 186.46M |
| Alnylam Pharmaceuticals, Inc. | 5.130B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 39.64M |
| Shareholders Equity (Quarterly) | 513.96M |
| Debt to Equity Ratio | 0.0028 |
| Current Ratio | 13.85 |
| Net Debt Paydown Yield | -0.01% |